As of 2026-04-06, the EV/EBITDA ratio of Sumitomo Dainippon Pharma Co Ltd (4506.T) is 6.86. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4506.T's latest enterprise value is 1,006,184.80 mil JPY. 4506.T's TTM EBITDA according to its financial statements is 146,698.00 mil JPY. Dividing these 2 quantities gives us the above 4506.T EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.3x - 10.2x | 8.8x |
| Forward P/E multiples | 8.2x - 10.8x | 9.4x |
| Fair Price | 453.81 - 3,246.43 | 1,672.30 |
| Upside | -77.6% - 60.6% | -17.3% |
| Date | EV/EBITDA |
| 2026-04-01 | 7.43 |
| 2026-03-31 | 7.00 |
| 2026-03-30 | 7.09 |
| 2026-03-27 | 7.25 |
| 2026-03-26 | 6.88 |
| 2026-03-25 | 6.78 |
| 2026-03-24 | 6.53 |
| 2026-03-23 | 6.17 |
| 2026-03-19 | 6.40 |
| 2026-03-18 | 6.49 |
| 2026-03-17 | 6.39 |
| 2026-03-16 | 6.24 |
| 2026-03-13 | 6.35 |
| 2026-03-12 | 6.44 |
| 2026-03-11 | 6.50 |
| 2026-03-10 | 6.55 |
| 2026-03-09 | 6.47 |
| 2026-03-06 | 6.58 |
| 2026-03-05 | 6.38 |
| 2026-03-04 | 6.49 |
| 2026-03-03 | 6.69 |
| 2026-03-02 | 7.94 |
| 2026-02-27 | 8.22 |
| 2026-02-26 | 8.00 |
| 2026-02-25 | 7.73 |
| 2026-02-24 | 7.45 |
| 2026-02-20 | 8.09 |
| 2026-02-19 | 9.33 |
| 2026-02-18 | 9.31 |
| 2026-02-17 | 10.01 |
| 2026-02-16 | 9.43 |
| 2026-02-13 | 8.08 |
| 2026-02-12 | 7.86 |
| 2026-02-10 | 7.80 |
| 2026-02-09 | 7.48 |
| 2026-02-06 | 7.42 |
| 2026-02-05 | 7.66 |
| 2026-02-04 | 7.58 |
| 2026-02-03 | 7.27 |
| 2026-02-02 | 7.46 |
| 2026-01-30 | 7.60 |
| 2026-01-29 | 7.29 |
| 2026-01-28 | 7.51 |
| 2026-01-27 | 7.75 |
| 2026-01-26 | 7.70 |
| 2026-01-23 | 7.51 |
| 2026-01-22 | 7.38 |
| 2026-01-21 | 7.54 |
| 2026-01-20 | 7.49 |
| 2026-01-19 | 7.85 |